Norihito Omote

1.5k total citations
20 papers, 226 citations indexed

About

Norihito Omote is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Norihito Omote has authored 20 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Norihito Omote's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Cancer-related molecular mechanisms research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Norihito Omote is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Cancer-related molecular mechanisms research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Norihito Omote collaborates with scholars based in Japan and United States. Norihito Omote's co-authors include Yoshinori Hasegawa, Koji Sakamoto, Naozumi Hashimoto, Akira Ando, Kazuyoshi Imaizumi, Tsutomu Kawabe, Maor Sauler, Shinichi Miyazaki, Yoshio Nakahara and Motohiro Kimura and has published in prestigious journals such as Scientific Reports, CHEST Journal and European Respiratory Journal.

In The Last Decade

Norihito Omote

19 papers receiving 224 citations

Peers

Countries citing papers authored by Norihito Omote

Since Specialization

Citations

This map shows the geographic impact of Norihito Omote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihito Omote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihito Omote more than expected).

Fields of papers citing papers by Norihito Omote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihito Omote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihito Omote. The network helps show where Norihito Omote may publish in the future.

Co-authorship network of co-authors of Norihito Omote

This figure shows the co-authorship network connecting the top 25 collaborators of Norihito Omote. A scholar is included among the top collaborators of Norihito Omote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihito Omote. Norihito Omote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of acute phase intensive electrical muscle stimulation in COVID-19 patients requiring invasive mechanical ventilation: an observational case-control study 2024 ·Scientific Reports ·(unknown), Shinya Tanaka, Daisuke Kasugai, (unknown), Miho Shimizu, Takayuki Inoue, Motoki Nagaya, (unknown), Norihito Omote, (unknown), Takanori Yamamoto, (unknown), Atsushi Numaguchi, (unknown)	1
2	Physical function and mental health trajectories in COVID-19 patients following invasive mechanical ventilation: a prospective observational study 2023 ·Scientific Reports ·Hiromasa Yamamoto, Shinya Tanaka, Daisuke Kasugai, Miho Shimizu, (unknown), (unknown), (unknown), Takayuki Inoue, Motoki Nagaya, Norihito Omote, (unknown), Takanori Yamamoto, (unknown), Atsushi Numaguchi, Yukari Goto, (unknown)	4
3	Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment? 2023 ·Respiratory Medicine Case Reports ·(unknown), Atsushi Suzuki, Kensuke Fukumitsu, (unknown), (unknown), Makoto Ishii, Akio Niimi, Kazuyoshi Imaizumi, Koji Sakamoto, Norihito Omote, Etsuro Yamaguchi	0
4	BMP3b is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts 2022 ·American Journal of Respiratory Cell and Molecular Biology ·Atsushi Suzuki, Koji Sakamoto, Yoshio Nakahara, Atsushi Enomoto, Jun Hino, Akira Ando, Masahide Inoue, Yukihiro Shiraki, Norihito Omote, Masahiro KUSAKA, Jun Fukihara, Naozumi Hashimoto	7
5	COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review 2022 ·Frontiers in Medicine ·(unknown), Koji Sakamoto, Jun Fukihara, Atsushi Suzuki, Norihito Omote, Akira Ando, Yuichiro Shindo, Naozumi Hashimoto	7
6	Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis 2021 ·European Respiratory Journal ·Yoshio Nakahara, Naozumi Hashimoto, Koji Sakamoto, Atsushi Enomoto, Taylor Adams, Toyoharu Yokoi, Norihito Omote, Sergio Poli, Akira Ando, Keiko Wakahara, Atsushi Suzuki, Masahide Inoue, Akitoshi Hara, Yasuyuki Mizutani, Kazuyoshi Imaizumi, Tsutomu Kawabe, Iván O. Rosas, Masahide Takahashi, Naftali Kaminski, Yoshinori Hasegawa	27
7	Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19 2021 ·Internal Medicine ·Norihito Omote, Yoshihiro Kanemitsu, Takahiro Inoue, (unknown), (unknown), Yuichiro Shindo, Koji Sakamoto, Akira Ando, Atsushi Suzuki, Akio Niimi, Satoru Ito, Kazuyoshi Imaizumi, Naozumi Hashimoto	7
8	Usefulness of Respiratory Mechanics and Laboratory Parameter Trends as Markers of Early Treatment Success in Mechanically Ventilated Severe Coronavirus Disease: A Single-Center Pilot Study 2021 ·Journal of Clinical Medicine ·Daisuke Kasugai, Masayuki Ozaki, Kazuki Nishida, Hiroaki Hiraiwa, (unknown), Atsushi Numaguchi, Norihito Omote, Yuichiro Shindo, Yukari Goto	7
9	Long noncoding RNA TINCR is a novel regulator of human bronchial epithelial cell differentiation state 2021 ·Physiological Reports ·Norihito Omote, Koji Sakamoto, Qin Li, Jonas C. Schupp, Taylor Adams, Farida Ahangari, Maurizio Chioccioli, Giuseppe DeIuliis, Naozumi Hashimoto, Yoshinori Hasegawa, Naftali Kaminski	6
10	Non-coding RNAs as Regulators of Cellular Senescence in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease 2020 ·Frontiers in Medicine ·Norihito Omote, Maor Sauler	13
11	Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β‐induced extracellular matrix production in lung cancer cells 2019 ·Cancer Science ·Akira Ando, Naozumi Hashimoto, Koji Sakamoto, Norihito Omote, Shinichi Miyazaki, Yoshio Nakahara, Kazuyoshi Imaizumi, Tsutomu Kawabe, Yoshinori Hasegawa	20
12	TINCR, a Long Intergenic Noncoding RNA Decreased in IPF, Is a Novel Regulator of Airway Epithelial Cell Differentiation 2019 ·Norihito Omote, Koji Sakamoto, (unknown), Jonas C. Schupp, Thomas G. Adams, Farida Ahangari, Maurizio Chioccioli, Nikos Xylourgidis, Giuseppe DeIuliis, Naoyuki Hashimoto, Yoshinori Hasegawa, Naftali Kaminski	1
13	An <i>EGFR</i>-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib 2018 ·Internal Medicine ·Mitsuo Sato, Akira Matsui, Yoshie Shimoyama, Norihito Omote, Masahiro Morise, Tetsunari Hase, Ichidai Tanaka, Kojiro Suzuki, Yoshinori Hasegawa	8
14	Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy 2017 ·International Journal of COPD ·Norihito Omote, Naozumi Hashimoto, Masahiro Morise, Koji Sakamoto, Shinichi Miyazaki, Akira Ando, Yoshio Nakahara, Yoshinori Hasegawa	17
15	Decreased expression of FENDRR, a lung mesenchymal long non-coding RNA, regulates fibroblast phenotypes in IPF through NOX4 2017 ·Koji Sakamoto, Nikos Xylourgidis, Norihito Omote, Taylor Adams, Guoying Yu, Farida Ahangari, Jose D. Herazo‐Maya, Naftali Kaminski, Robert Homer	2
16	Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung cancers 2016 ·Cancer Cell International ·(unknown), Naozumi Hashimoto, Akira Ando, Koji Sakamoto, Shinichi Miyazaki, (unknown), (unknown), Motohiro Kimura, Norihito Omote, Kazuyoshi Imaizumi, Tsutomu Kawabe, Yoshinori Hasegawa	38
17	Acute respiratory distress syndrome due to severe pulmonary tuberculosis treated with extracorporeal membrane oxygenation: A case report and review of the literature 2016 ·Respiratory Medicine Case Reports ·Norihito Omote, Yasuhiro Kondoh, Hiroyuki Taniguchi, Tomoki Kimura, Kensuke Kataoka, Ryuichi Hasegawa, Yoshinori Hasegawa	9
18	Exogenous induction of unphosphorylated PTEN reduces TGFβ‐induced extracellular matrix expressions in lung fibroblasts 2016 ·Wound Repair and Regeneration ·Motohiro Kimura, Naozumi Hashimoto, (unknown), (unknown), Koji Sakamoto, Shinichi Miyazaki, Akira Ando, Norihito Omote, Kazuyoshi Imaizumi, Tsutomu Kawabe, Yoshinori Hasegawa	8
19	Lung-Dominant Connective Tissue Disease 2015 ·CHEST Journal ·Norihito Omote, Hiroyuki Taniguchi, Yasuhiro Kondoh, Naohiro Watanabe, Koji Sakamoto, Tomoki Kimura, Kensuke Kataoka, Takeshi Johkoh, Kiminori Fujimoto, Junya Fukuoka, Kyoko Otani, Osamu Nishiyama, Yoshinori Hasegawa	36
20	Direct regulation of transforming growth factor β‐induced epithelial–mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells 2015 ·Cancer Science ·(unknown), Naozumi Hashimoto, Motohiro Kimura, (unknown), (unknown), Koji Sakamoto, Shinichi Miyazaki, Akira Ando, Norihito Omote, Kazuyoshi Imaizumi, Tsutomu Kawabe, Yoshinori Hasegawa	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact